Citation Impact
Citing Papers
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
2001 StandoutScience
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
2009 Standout
Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation
2007
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census
2004
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients
2009
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin
2003
Bowel Disorders
2016 Standout
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome
2005
Ulcerative Colitis
2011 Standout
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy
2002 Standout
Guidelines for the management of inflammatory bowel disease in adults
2011
Cushing's syndrome
2015 Standout
Serotonin and Its Role in Colonic Function and in Gastrointestinal Disorders
2006
Use of thiopurines in inflammatory bowel disease: Safety issues
2014
Renal-Cell Carcinoma
1996 Standout
Medical Treatment of Cushing's Disease
2013
O-carboxymethyl-O-ethylcyclomalthoheptaose as a delayed-release-type drug carrier: improvement of the oral bioavailability of diltiazem in the dog
1989
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Albumin–drug interaction and its clinical implication
2013 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Crohn's disease
2012 Standout
Slow-Release Characteristics of Diltiazem from Ethylated β-Cyclodextrin Complexes
1990
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype
2005
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
A Prospective Natural-History Study of Coronary Atherosclerosis
2011 Standout
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
2007
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Targeting multidrug resistance in cancer
2006 Standout
Ulcerative colitis
2012 Standout
Will tomorrow's medicines work for everyone?
2004
Interaction of Warfarin With Drugs, Natural Substances, and Foods
2005
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Computational design of an enantioselective molecular imprinted polymer for the solid phase extraction of S-warfarin from plasma
2014
Crohn's disease
2016 Standout
Can oxidative damage be treated nutritionally?
2005
Common VKORC1 and GGCX polymorphisms associated with warfarin dose
2005
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
A new high-performance liquid chromatographic method for determination of warfarin enantiomers
2005 StandoutNobel
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Pharmacological Importance of Stereochemical Resolution of Enantiomeric Drugs
1997
Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment
1999
Ulcerative colitis
2016 Standout
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
Pharmacological considerations in the modulation of multidrug resistance
1996
Several-fold increase in risk of overanticoagulation by CYP2C9 mutations
2005
Programmed cell death: its possible contribution to neurotoxicity mediated by calcium channel antagonists
1992
Crystal structure of human cytochrome P450 2C9 with bound warfarin
2003 Nature
Clopidogrel and proton pump inhibitors - where do we stand in 2012?
2012
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
2009
Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinoma.
1995
Rome III Functional Constipation and Irritable Bowel Syndrome With Constipation Are Similar Disorders Within a Spectrum of Sensitization, Regulated by Serotonin
2013
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Determination of phenprocoumon, warfarin and their monohydroxylated metabolites in human plasma and urine by liquid chromatography–mass spectrometry after solid-phase extraction
2004
CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differences
2004
haplotype structure in European American warfarin patients and association with clinical outcomes
2005
Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records
2006 StandoutNobel
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Crosstalk at the mucosal border: importance of the gut microenvironment in IBS
2014
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy.
1995
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Determination of warfarin enantiomers and hydroxylated metabolites in human blood plasma by liquid chromatography with achiral and chiral separation
2005
An electrochemical sensor based on multiwall carbon nanotubes and molecular imprinting strategy for warfarin recognition and determination
2014
Pharmacokinetics and Pharmacodynamics of Famotidine in Infants
1998
Irritable Bowel Syndrome
2015 Standout
Gastrointestinal pain in functional bowel disorders: sensory neurons as novel drug targets
2004
Usefulness of coadministration of bucolome in warfarin therapy: pharmacokinetic and pharmacodynamic analysis using outpatient prescriptions
2005
A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity
2005
Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome
2012
Docking and scoring in virtual screening for drug discovery: methods and applications
2004 Standout
Cyclodextrin Drug Carrier Systems
1998 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis
1997 StandoutNobel
Effects of Anticoagulation Intensity on Hemostatic Markers in Patients With Non-Valvular Atrial Fibrillation
2003
Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and γ-glutamyl carboxylase) gene variants with warfarin sensitivity
2003
Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein
1992
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Dynamic Inversion of Stereoselective Phosphate Binding to a Bisurea Receptor Controlled by Light and Heat
2015 StandoutNobel
Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma
1999 Standout
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
Racial-Ethnic Disparities in Stroke Care: The American Experience
2011 Standout
A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin
2004
Risks and Benefits of Combined Use of Bucolome and Warfarin in Anticoagulation Therapy
2010
Molecular imprinting: perspectives and applications
2016 Standout
Structure and Chemistry of Cytochrome P450
2005 Standout
Works of Hirotoshi Echizen being referenced
Active oxygen species generation and cellular damage by additives of parenteral preparations: selenium and sulfhydryl compounds
1999
Determination of unbound warfarin enantiomers in human plasma and 7-hydroxywarfarin in human urine by chiral stationary-phase liquid chromatography with ultraviolet or fluorescence and on-line circular dichroism detection
1997
Drug-Drug Interaction Profiles of Proton Pump Inhibitors
2010
Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes
1998
Pharmacogenetics of Warfarin Elimination and its Clinical Implications
2001
Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes*
1998
Clinical Pharmacokinetics of Famotidine
1991
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans
2006
Patients with Constipation-Predominant Irritable Bowel Syndrome (IBS) May Have Elevated Serotonin Concentrations in Colonic Mucosa as Compared with Diarrhea-Predominant Patients and Subjects with Normal Bowel Habits
2001
Plasma famotidine concentration versus intragastric pH in patients with upper gastrointestinal bleeding and in healthy subjects
1988
Effects of d,l-verapamil on atrioventricular conduction in relation to its stereoselective first-pass metabolism
1985
Clinical Pharmacokinetics of Verapamil, Nifedipine and Diltiazem
1986
Population differences in S‐warfarin metabolism between CYP2C9 genotype‐matched Caucasian and Japanese patients
2003
5′-Flanking region polymorphisms of CYP2C9 and their relationship to S-warfarin metabolism in white and Japanese patients
2004
Meta-Analysis of Risk of Malignancy with Immunosuppressive Drugs in Inflammatory Bowel Disease
2007
The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans
1985
Dose‐dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6β‐hydroxycortisol
2002
Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
1999